Natural history studies in neuromuscular junction (NMJ) disease mouse models. Period of performance september 28, 2020 - december 31, 2021
Ended Awarded Last action
- Contract number
- 75N95020F00003
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,011,717
Award facts
- Opportunity
-
- 75N95020R00051 Solicitation number
- Contract value 85% obligated
-
- $2,011,717.00 Current, with exercised options
- $2,366,151.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $16,749 | |
| Supplemental Agreement for work within scope | $439,560 | |
| Supplemental Agreement for work within scope | $63,495 | |
| Original award | $1,491,913 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract is for natural history studies in neuromuscular junction (NMJ) disease mouse models, with a period of performance from September 28, 2020 to December 31, 2021 and a total ceiling value of $2,366,151.00. The contract does not have a set-aside designation. Lovelace Biomedical Research Institute has expertise in areas like animal studies, analytical testing, disease model development, and product manufacturing, and supports federal agencies such as NIH, DoD, and HHS with a wide array of preclinical research services.
Quick answers
Who was awarded contract 75N95020F00003?
75N95020F00003 was awarded to Lovelace Biomedical Research Institute by National Institute on Drug Abuse (National Institutes of Health) on September 28, 2020.
How much is contract 75N95020F00003 worth?
The government has obligated $2,011,717 on 75N95020F00003. Its potential value, with all options, is $2,366,151.
Is contract 75N95020F00003 an order under another contract?
Yes. 75N95020F00003 is a delivery order under 75N95019D00012, an indefinite delivery contract.
Was contract 75N95020F00003 competed?
The extent of competition for 75N95020F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award